Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Docetaxel × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 125 Esophageal Neoplasms 66 Pancreatic Neoplasms 37 Esophageal Squamous Cell Carcinoma 23 Adenocarcinoma Of Esophagus 23 Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 16 Neoplasms 13 Colorectal Neoplasms 12 Neoplasm Metastasis 11 Prostatic Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Melanoma 8 Lung Neoplasms 7 Biliary Tract Neoplasms 7 Adenocarcinoma 7 Sarcoma 6 Colonic Neoplasms 6 Urinary Bladder Neoplasms 5 Small Cell Lung Carcinoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Gallbladder Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Head and Neck Neoplasms 4 Gastrointestinal Neoplasms 4 Esthesioneuroblastoma, Olfactory 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3

Interventions

Fluorouracil 8 Cisplatin 7 Radiotherapy 6 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Mitomycin 3 Capecitabine 3 dehydroftorafur 2 Radiation 2 Nivolumab 2 Cetuximab 2 Biopsy 2 toripalimab 1 pembrolizumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 Taxes 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Mitozytrex 1 Mitomycins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02402842 2022-05-16

Epitopes-HPV02

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡